[1]
|
Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A., et al. (2020) Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology, 159, 335-349.e15. https://doi.org/10.1053/j.gastro.2020.02.068
|
[2]
|
Chen, X., Gole, J., Gore, A., He, Q., Lu, M., Min, J., et al. (2020) Non-Invasive Early Detection of Cancer Four Years before Conventional Diagnosis Using a Blood Test. Nature Communications, 11, Article No. 3475. https://doi.org/10.1038/s41467-020-17316-z
|
[3]
|
Najafi, S., Majidpoor, J. and Mortezaee, K. (2024) Liquid Biopsy in Colorectal Cancer. Clinica Chimica Acta, 553, Article ID: 117674. https://doi.org/10.1016/j.cca.2023.117674
|
[4]
|
Huang, Z., Zhu, D., Wu, L., He, M., Zhou, X., Zhang, L., et al. (2017) Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology, Biomarkers & Prevention, 26, 188-196. https://doi.org/10.1158/1055-9965.epi-16-0607
|
[5]
|
Deboever, N., Jones, C.M., Yamashita, K., Ajani, J.A. and Hofstetter, W.L. (2024) Advances in Diagnosis and Management of Cancer of the Esophagus. BMJ, 385, e074962. https://doi.org/10.1136/bmj-2023-074962
|
[6]
|
Qu, J., Li, Y., Liu, G., Li, Z., Zhong, N., Zhang, M., et al. (2023) Optimal Concentration of Lugol’s Solution for Detecting Early Esophageal Carcinoma: A Randomized Controlled Trial. Journal of Gastroenterology and Hepatology, 38, 962-969. https://doi.org/10.1111/jgh.16190
|
[7]
|
Tanaka, Y., Kamohara, H., Kinoshita, K., Kurashige, J., Ishimoto, T., Iwatsuki, M., et al. (2012) Clinical Impact of Serum Exosomal Microrna‐21 as a Clinical Biomarker in Human Esophageal Squamous Cell Carcinoma. Cancer, 119, 1159-1167. https://doi.org/10.1002/cncr.27895
|
[8]
|
Wang, L., Liu, H., Wu, Q., Liu, Y., Yan, Z., Chen, G., et al. (2024) miR-451a Was Selectively Sorted into Exosomes and Promoted the Progression of Esophageal Squamous Cell Carcinoma through CAB39. Cancer Gene Therapy, 31, 1060-1069. https://doi.org/10.1038/s41417-024-00774-8
|
[9]
|
Xu, M., Liu, T., Dong, F., Meng, L., Ling, A. and Liu, S. (2021) Exosomal Lncrna LINC01711 Facilitates Metastasis of Esophageal Squamous Cell Carcinoma via the miR-326/FSCN1 Axis. Aging, 13, 19776-19788. https://doi.org/10.18632/aging.203389
|
[10]
|
Rao, D., Lu, H., Wang, X., Lai, Z., Zhang, J. and Tang, Z. (2023) Tissue-Derived Exosome Proteomics Identifies Promising Diagnostic Biomarkers for Esophageal Cancer. eLife, 12, e86209. https://doi.org/10.7554/elife.86209
|
[11]
|
Zhang, C., Guo, Z. and Jing, Z. (2024) Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma. International Journal of Nanomedicine, 19, 1351-1362. https://doi.org/10.2147/ijn.s440684
|
[12]
|
Xie, C., Chen, X., Chen, Y., Wang, X., Zuo, J., Zheng, A., et al. (2023) Mutual Communication between Radiosensitive and Radioresistant Esophageal Cancer Cells Modulates Their Radiosensitivity. Cell Death & Disease, 14, Article No. 846. https://doi.org/10.1038/s41419-023-06307-9
|
[13]
|
Wang, Z., Zhang, M., Liu, L., Yang, Y., Qiu, J., Yu, Y., et al. (2023) Prognostic and Immunological Role of Cancer-Associated Fibroblasts-Derived Exosomal Protein in Esophageal Squamous Cell Carcinoma. International Immunopharmacology, 124, Article ID: 110837. https://doi.org/10.1016/j.intimp.2023.110837
|
[14]
|
Yan, D., Cui, D., Zhu, Y., Chan, C.K.W., Choi, C.H.J., Liu, T., et al. (2023) M6PR-And EphB4-Rich Exosomes Secreted by Serglycin-Overexpressing Esophageal Cancer Cells Promote Cancer Progression. International Journal of Biological Sciences, 19, 625-640. https://doi.org/10.7150/ijbs.79875
|
[15]
|
Zhang, X. and Zhang, P. (2016) Gastric Cancer: Somatic Genetics as a Guide to Therapy. Journal of Medical Genetics, 54, 305-312. https://doi.org/10.1136/jmedgenet-2016-104171
|
[16]
|
Fujishiro, M. (2024) Advanced Diagnostic and Therapeutic Endoscopy for Early Gastric Cancer. Cancers, 16, Article 1039. https://doi.org/10.3390/cancers16051039
|
[17]
|
Shen, M., Wang, H., Wei, K., Zhang, J. and You, C. (2018) Five Common Tumor Biomarkers and CEA for Diagnosing Early Gastric Cancer: A Protocol for a Network Meta-Analysis of Diagnostic Test Accuracy. Medicine, 97, e0577. https://doi.org/10.1097/md.0000000000010577
|
[18]
|
Yang, A., Liu, J., Lei, H., Zhang, Q., Zhao, L. and Yang, G. (2014) CA72-4 Combined with CEA, CA125 and CAL9-9 Improves the Sensitivity for the Early Diagnosis of Gastric Cancer. Clinica Chimica Acta, 437, 183-186. https://doi.org/10.1016/j.cca.2014.07.034
|
[19]
|
Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2013) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[20]
|
Chen, Y., Wang, B., Zhao, Y., Shao, X., Wang, M., Ma, F., et al. (2024) Metabolomic Machine Learning Predictor for Diagnosis and Prognosis of Gastric Cancer. Nature Communications, 15, Article No. 1657. https://doi.org/10.1038/s41467-024-46043-y
|
[21]
|
Li, S., Zhang, M., Zhang, H., Hu, K., Cai, C., Wang, J., et al. (2020) Exosomal Long Noncoding RNA Lnc-GNAQ-6:1 May Serve as a Diagnostic Marker for Gastric Cancer. Clinica Chimica Acta, 501, 252-257. https://doi.org/10.1016/j.cca.2019.10.047
|
[22]
|
Sun, Y., Jin, J., Jing, H., Lu, Y., Zhu, Q., Shu, C., et al. (2021) ITIH4 Is a Novel Serum Biomarker for Early Gastric Cancer Diagnosis. Clinica Chimica Acta, 523, 365-373. https://doi.org/10.1016/j.cca.2021.10.022
|
[23]
|
Zheng, G., Xu, Z., Hu, C., Lv, H., Xie, H., Huang, T., et al. (2021) Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer. Frontiers in Molecular Biosciences, 8, Article 636566. https://doi.org/10.3389/fmolb.2021.636566
|
[24]
|
Wang, H., Zeng, X., Zheng, Y., Wang, Y. and Zhou, Y. (2021) Exosomal Circrna in Digestive System Tumors: The Main Player or Coadjuvants? Frontiers in Oncology, 11, Article 614462. https://doi.org/10.3389/fonc.2021.614462
|
[25]
|
Song, Q., Lv, X., Ru, Y., Dong, J., Chang, R., Wu, D., et al. (2022) Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Noninvasive Biomarker for Predicting Chemotherapy Response and Prognosis of Advanced Gastric Cancer: A Multi-Cohort, Multi-Phase Study. eBioMedicine, 78, Article ID: 103971. https://doi.org/10.1016/j.ebiom.2022.103971
|
[26]
|
Tang, X., Guo, T., Gao, X., Wu, X., Xing, X., Ji, J., et al. (2021) Exosome-Derived Noncoding Rnas in Gastric Cancer: Functions and Clinical Applications. Molecular Cancer, 20, Article No. 99. https://doi.org/10.1186/s12943-021-01396-6
|
[27]
|
Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Cancer Statistics, 2024. CA: A Cancer Journal for Clinicians, 74, 12-49. https://doi.org/10.3322/caac.21820
|
[28]
|
Wolf, A.M.D., Fontham, E.T.H., Church, T.R., Flowers, C.R., Guerra, C.E., LaMonte, S.J., et al. (2018) Colorectal Cancer Screening for Average‐risk Adults: 2018 Guideline Update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 68, 250-281. https://doi.org/10.3322/caac.21457
|
[29]
|
Zhao, S., Wang, S., Pan, P., Xia, T., Chang, X., Yang, X., et al. (2019) Magnitude, Risk Factors, and Factors Associated with Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-Analysis. Gastroenterology, 156, 1661-1674.E11. https://doi.org/10.1053/j.gastro.2019.01.260
|
[30]
|
Dong, X., Du, L., Luo, Z., Xu, Y., Wang, C., Wang, F., et al. (2024) Combining Fecal Immunochemical Testing and Questionnaire-Based Risk Assessment in Selecting Participants for Colonoscopy Screening in the Chinese National Colorectal Cancer Screening Programs: A Population-Based Cohort Study. PLOS Medicine, 21, e1004340. https://doi.org/10.1371/journal.pmed.1004340
|
[31]
|
Yen, A.M., Hsu, C., Lin, T., Su, C., Chiu, H., Chen, T.H., et al. (2024) Precision Colorectal Cancer Fecal Immunological Test Screening with Fecal-Hemoglobin-Concentration-Guided Interscreening Intervals. JAMA Oncology, 10, 765-772. https://doi.org/10.1001/jamaoncol.2024.0961
|
[32]
|
Ladabaum, U., Dominitz, J.A., Kahi, C. and Schoen, R.E. (2020) Strategies for Colorectal Cancer Screening. Gastroenterology, 158, 418-432. https://doi.org/10.1053/j.gastro.2019.06.043
|
[33]
|
Yoon, J.H., Yu, M.H., Hur, B.Y., Park, C.M. and Lee, J.M. (2020) Detection of Distant Metastases in Rectal Cancer: Contrast-Enhanced CT vs Whole Body MRI. European Radiology, 31, 104-111. https://doi.org/10.1007/s00330-020-07149-1
|
[34]
|
Meyer, M., Ronald, J., Vernuccio, F., Nelson, R.C., Ramirez-Giraldo, J.C., Solomon, J., et al. (2019) Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings. Radiology, 293, 583-591. https://doi.org/10.1148/radiol.2019190928
|
[35]
|
Hao, C., Sui, Y., Li, J., Shi, Y. and Zou, Z. (2021) The Clinical Value of the Combined Detection of Enhanced CT, MRI, CEA, and CA199 in the Diagnosis of Rectal Cancer. Journal of Oncology, 2021, Article ID: 8585371. https://doi.org/10.1155/2021/8585371
|
[36]
|
Min, L., Zhu, S., Chen, L., Liu, X., Wei, R., Zhao, L., et al. (2019) Evaluation of Circulating Small Extracellular Vesicles Derived miRNAs as Biomarkers of Early Colon Cancer: A Comparison with Plasma Total miRNAs. Journal of Extracellular Vesicles, 8, Article ID: 1643670. https://doi.org/10.1080/20013078.2019.1643670
|
[37]
|
Wu, Y., Zhang, J., Lin, F., Zhao, Y., Zheng, B., Zhou, N., et al. (2024) Exosomal miR‐1470 Is a Diagnostic Biomarker and Promotes Cell Proliferation and Metastasis in Colorectal Cancer. Cancer Medicine, 13, e7117. https://doi.org/10.1002/cam4.7117
|
[38]
|
Wang, D., Wang, X., Si, M., Yang, J., Sun, S., Wu, H., et al. (2020) Exosome-encapsulated miRNAs Contribute to Cxcl12/cxcr4-Induced Liver Metastasis of Colorectal Cancer by Enhancing M2 Polarization of Macrophages. Cancer Letters, 474, 36-52. https://doi.org/10.1016/j.canlet.2020.01.005
|
[39]
|
Liang, G., Zhu, Y., Ali, D.J., Tian, T., Xu, H., Si, K., et al. (2020) Engineered Exosomes for Targeted Co-Delivery of miR-21 Inhibitor and Chemotherapeutics to Reverse Drug Resistance in Colon Cancer. Journal of Nanobiotechnology, 18, Article No. 10. https://doi.org/10.1186/s12951-019-0563-2
|
[40]
|
Magliacane Trotta, S., Adinolfi, A., D’Orsi, L., Panico, S., Mercadante, G., Mehlen, P., et al. (2024) Cancer-Derived Exosomal Alu RNA Promotes Colorectal Cancer Progression. Experimental & Molecular Medicine, 56, 700-710. https://doi.org/10.1038/s12276-024-01166-6
|
[41]
|
Yu, X., Bu, C., Yang, X., Jiang, W., He, X., Sun, R., et al. (2024) Exosomal Non-Coding RNAs in Colorectal Cancer Metastasis. Clinica Chimica Acta, 556, Article ID: 117849. https://doi.org/10.1016/j.cca.2024.117849
|
[42]
|
Al-Joufi, F., Setia, A., Salem-Bekhit, M., Sahu, R., Alqahtani, F., Widyowati, R., et al. (2022) Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches. Nanomaterials, 12, Article 169. https://doi.org/10.3390/nano12010169
|
[43]
|
Li, J., Zhang, G., Liu, C., Xiang, X., Le, M.T.N., Sethi, G., et al. (2022) The Potential Role of Exosomal Circrnas in the Tumor Microenvironment: Insights into Cancer Diagnosis and Therapy. Theranostics, 12, 87-104. https://doi.org/10.7150/thno.64096
|
[44]
|
Hoshino, A., Kim, H.S., Bojmar, L., Gyan, K.E., Cioffi, M., Hernandez, J., et al. (2020) Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell, 182, 1044-1061.E18. https://doi.org/10.1016/j.cell.2020.07.009
|
[45]
|
Liang, J.Q., Li, T., Nakatsu, G., Chen, Y., Yau, T.O., Chu, E., et al. (2019) A Novel Faecal Lachnoclostridium Marker for the Non-Invasive Diagnosis of Colorectal Adenoma and Cancer. Gut, 69, 1248-1257. https://doi.org/10.1136/gutjnl-2019-318532
|
[46]
|
Grady, W.M., Yu, M. and Markowitz, S.D. (2021) Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology, 160, 690-709. https://doi.org/10.1053/j.gastro.2020.09.058
|
[47]
|
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., et al. (2020) Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer, 9, 682-720. https://doi.org/10.1159/000509424
|
[48]
|
Galle, P.R., Forner, A., Llovet, J.M., Mazzaferro, V., Piscaglia, F., Raoul, J., et al. (2018) EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Journal of Hepatology, 69, 182-236. https://doi.org/10.1016/j.jhep.2018.03.019
|
[49]
|
Marrero, J.A., Kulik, L.M., Sirlin, C.B., Zhu, A.X., Finn, R.S., Abecassis, M.M., et al. (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 68, 723-750. https://doi.org/10.1002/hep.29913
|
[50]
|
Kudo, M., Kawamura, Y., Hasegawa, K., Tateishi, R., Kariyama, K., Shiina, S., et al. (2021) Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer, 10, 181-223. https://doi.org/10.1159/000514174
|
[51]
|
Kubo, S., Shinkawa, H., Asaoka, Y., Ioka, T., Igaki, H., Izumi, N., et al. (2022) Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma. Liver Cancer, 11, 290-314. https://doi.org/10.1159/000522403
|
[52]
|
Tzartzeva, K., Obi, J., Rich, N.E., Parikh, N.D., Marrero, J.A., Yopp, A., et al. (2018) Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis: A Meta-Analysis. Gastroenterology, 154, 1706-1718.E1. https://doi.org/10.1053/j.gastro.2018.01.064
|
[53]
|
Sanduzzi-Zamparelli, M., Mariño, Z., Lens, S., Sapena, V., Iserte, G., Pla, A., et al. (2022) Liver Cancer Risk after HCV Cure in Patients with Advanced Liver Disease without Non-Characterized Nodules. Journal of Hepatology, 76, 874-882. https://doi.org/10.1016/j.jhep.2021.11.023
|
[54]
|
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., et al. (2022) BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update. Journal of Hepatology, 76, 681-693. https://doi.org/10.1016/j.jhep.2021.11.018
|
[55]
|
Singal, A.G., Lampertico, P. and Nahon, P. (2020) Epidemiology and Surveillance for Hepatocellular Carcinoma: New Trends. Journal of Hepatology, 72, 250-261. https://doi.org/10.1016/j.jhep.2019.08.025
|
[56]
|
Xie, D., Ren, Z., Zhou, J., Fan, J. and Gao, Q. (2020) 2019 Chinese Clinical Guidelines for the Management of Hepatocellular Carcinoma: Updates and Insights. Hepatobiliary Surgery and Nutrition, 9, 452-463. https://doi.org/10.21037/hbsn-20-480
|
[57]
|
Heimbach, J.K., Kulik, L.M., Finn, R.S., Sirlin, C.B., Abecassis, M.M., Roberts, L.R., et al. (2017) AASLD Guidelines for the Treatment of Hepatocellular Carcinoma. Hepatology, 67, 358-380. https://doi.org/10.1002/hep.29086
|
[58]
|
Ahn, J.C., Teng, P., Chen, P., Posadas, E., Tseng, H., Lu, S.C., et al. (2021) Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology, 73, 422-436. https://doi.org/10.1002/hep.31165
|
[59]
|
Gupta, S. (2003) Test Characteristics of Α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis. Annals of Internal Medicine, 139, 46-50. https://doi.org/10.7326/0003-4819-139-1-200307010-00012
|
[60]
|
Wei, X., Liu, L. and Zhu, F. (2022) Exosomes as Potential Diagnosis and Treatment for Liver Cancer. World Journal of Gastrointestinal Oncology, 14, 334-347. https://doi.org/10.4251/wjgo.v14.i1.334
|
[61]
|
Wang, J., Wang, X., Zhang, X., Shao, T., Luo, Y., Wang, W., et al. (2022) Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges. Frontiers in Oncology, 12, Article 884369. https://doi.org/10.3389/fonc.2022.884369
|
[62]
|
Lee, Y., Tran, B.V., Wang, J.J., Liang, I.Y., You, S., Zhu, Y., et al. (2021) The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers, 13, Article 3076. https://doi.org/10.3390/cancers13123076
|
[63]
|
Melo, S.A., Sugimoto, H., O’Connell, J.T., Kato, N., Villanueva, A., Vidal, A., et al. (2014) Cancer Exosomes Perform Cell-Independent Microrna Biogenesis and Promote Tumorigenesis. Cancer Cell, 26, 707-721. https://doi.org/10.1016/j.ccell.2014.09.005
|
[64]
|
Lin, H.T., Castaneda, A.F.A., Krishna, S.G. and Mumtaz, K. (2024) microRNAs in Hepatocellular Carcinoma Treatment: Charting the Path Forward. World Journal of Gastroenterology, 30, 1470-1474. https://doi.org/10.3748/wjg.v30.i11.1470
|
[65]
|
Ghosh, S., Bhowmik, S., Majumdar, S., Goswami, A., Chakraborty, J., Gupta, S., et al. (2020) The Exosome Encapsulated microRNAs as Circulating Diagnostic Marker for Hepatocellular Carcinoma with Low α‐Fetoprotein. International Journal of Cancer, 147, 2934-2947. https://doi.org/10.1002/ijc.33111
|
[66]
|
Sorop, A., Constantinescu, D., Cojocaru, F., Dinischiotu, A., Cucu, D. and Dima, S.O. (2021) Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma. International Journal of Molecular Sciences, 22, Article 4997. https://doi.org/10.3390/ijms22094997
|
[67]
|
Aydin, Y., Koksal, A.R., Thevenot, P., Chava, S., Heidari, Z., Lin, D., et al. (2021) Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma, 8, 1579-1596. https://doi.org/10.2147/jhc.s327339
|
[68]
|
Xing, M., Wang, X., Kirken, R., He, L. and Zhang, J. (2021) Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences, 22, Article 6139. https://doi.org/10.3390/ijms22116139
|
[69]
|
Qu, C., Wang, Y., Wang, P., Chen, K., Wang, M., Zeng, H., et al. (2019) Detection of Early-Stage Hepatocellular Carcinoma in Asymptomatic HBsAG-Seropositive Individuals by Liquid Biopsy. Proceedings of the National Academy of Sciences of the United States of America, 116, 6308-6312. https://doi.org/10.1073/pnas.1819799116
|
[70]
|
Zhu, L., Li, J., Gong, Y., Wu, Q., Tan, S., Sun, D., et al. (2019) Exosomal tRNA-Derived Small RNA as a Promising Biomarker for Cancer Diagnosis. Molecular Cancer, 18, Article No. 74. https://doi.org/10.1186/s12943-019-1000-8
|
[71]
|
Liu, W., Li, J., Zhang, P., Hou, Q., Feng, S., Liu, L., et al. (2019) A Novel Pan‐Cancer Biomarker Plasma Heat Shock Protein 90αand Its Diagnosis Determinants in Clinic. Cancer Science, 110, 2941-2959. https://doi.org/10.1111/cas.14143
|
[72]
|
Lei, X., Zhang, M., Guan, B., Chen, Q., Dong, Z. and Wang, C. (2021) Identification of Hub Genes Associated with Prognosis, Diagnosis, Immune Infiltration and Therapeutic Drug in Liver Cancer by Integrated Analysis. Human Genomics, 15, Article No. 39. https://doi.org/10.1186/s40246-021-00341-4
|